R. Herron

2.8k total citations
33 papers, 1.9k citations indexed

About

R. Herron is a scholar working on Hematology, Physiology and Management of Technology and Innovation. According to data from OpenAlex, R. Herron has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Physiology and 7 papers in Management of Technology and Innovation. Recurrent topics in R. Herron's work include Erythrocyte Function and Pathophysiology (8 papers), Blood groups and transfusion (8 papers) and Blood donation and transfusion practices (7 papers). R. Herron is often cited by papers focused on Erythrocyte Function and Pathophysiology (8 papers), Blood groups and transfusion (8 papers) and Blood donation and transfusion practices (7 papers). R. Herron collaborates with scholars based in United States, United Kingdom and Nigeria. R. Herron's co-authors include John B. Nobiletti, Timothy R. Church, Geary W. Olsen, Larry R. Zobel, William K. Reagen, David Mair, Jorge A. Rios, David A. Leiby, Beth A. Dy and Anne F. Eder and has published in prestigious journals such as The Lancet, Environmental Science & Technology and Clinical Infectious Diseases.

In The Last Decade

R. Herron

33 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Herron United States 17 981 842 337 280 268 33 1.9k
Jorge A. Rios United States 14 660 0.7× 563 0.7× 307 0.9× 54 0.2× 188 0.7× 25 1.4k
David Mair United States 16 781 0.8× 666 0.8× 252 0.7× 44 0.2× 218 0.8× 34 1.3k
Alain Berrébi France 41 221 0.2× 585 0.7× 27 0.1× 1.0k 3.7× 60 0.2× 160 5.4k
Calvin M. Menzie United States 7 37 0.0× 195 0.2× 22 0.1× 52 0.2× 24 0.1× 10 1.3k
Carsten Heilmann Denmark 33 1.1k 1.1× 1.1k 1.3× 3 0.0× 785 2.8× 207 0.8× 146 4.8k
Karen L. Warner United States 21 29 0.0× 62 0.1× 25 0.1× 348 1.2× 25 0.1× 35 1.2k
Stephen M. Hunt United States 18 31 0.0× 59 0.1× 37 0.1× 25 0.1× 57 0.2× 35 1.1k
Riccardo Masetti Italy 34 79 0.1× 76 0.1× 11 0.0× 282 1.0× 39 0.1× 147 3.2k
Shun‐Zhang Yu China 21 588 0.6× 185 0.2× 19 0.1× 246 0.9× 8 0.0× 41 1.7k
Daniele Zama Italy 23 79 0.1× 95 0.1× 6 0.0× 198 0.7× 20 0.1× 81 1.5k

Countries citing papers authored by R. Herron

Since Specialization
Citations

This map shows the geographic impact of R. Herron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Herron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Herron more than expected).

Fields of papers citing papers by R. Herron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Herron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Herron. The network helps show where R. Herron may publish in the future.

Co-authorship network of co-authors of R. Herron

This figure shows the co-authorship network connecting the top 25 collaborators of R. Herron. A scholar is included among the top collaborators of R. Herron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Herron. R. Herron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olsen, Geary W., David Mair, C. Lange, et al.. (2017). Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000–2015. Environmental Research. 157. 87–95. 226 indexed citations
2.
Eder, Anne F., Beth A. Dy, R. Herron, et al.. (2011). Donor survey to assess facial flushing during automated red cell collections and medication use. Journal of Clinical Apheresis. 26(3). 116–122. 1 indexed citations
3.
Bloch, Evan M., Barbara L. Herwaldt, David A. Leiby, et al.. (2011). The third described case of transfusion‐transmitted Babesia duncani. Transfusion. 52(7). 1517–1522. 66 indexed citations
4.
Olsen, Geary W., Mark Ellefson, David Mair, et al.. (2011). Analysis of a Homologous Series of Perfluorocarboxylates from American Red Cross Adult Blood Donors, 2000–2001 and 2006. Environmental Science & Technology. 45(19). 8022–8029. 42 indexed citations
5.
Eder, Anne F., R. Herron, Annie Strupp, et al.. (2010). Effective reduction of transfusion‐related acute lung injury risk with male‐predominant plasma strategy in the American Red Cross (2006‐2008). Transfusion. 50(8). 1732–1742. 120 indexed citations
6.
Moore, Anne, Laurene Mascola, Frank Steurer, et al.. (2009). Transmission ofTrypanosoma cruziby Heart Transplantation. Clinical Infectious Diseases. 48(11). 1534–1540. 71 indexed citations
7.
Leiby, David A., R. Herron, George Garratty, & Barbara L. Herwaldt. (2008). Trypanosoma cruzi Parasitemia in US Blood Donors with Serologic Evidence of Infection. The Journal of Infectious Diseases. 198(4). 609–613. 32 indexed citations
8.
Eder, Anne F., R. Herron, Annie Strupp, et al.. (2007). Transfusion‐related acute lung injury surveillance (2003‐2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 47(4). 599–607. 182 indexed citations
9.
Herron, R., et al.. (2005). A blood donor with bacteraemia. The Lancet. 365(9470). 1596–1596. 24 indexed citations
10.
Olsen, Geary W., Timothy R. Church, J. Philip Miller, et al.. (2003). Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors.. Environmental Health Perspectives. 111(16). 1892–1901. 346 indexed citations
11.
Herron, R., et al.. (2003). On bowling alone and donor recruitment: lessons to be learned. Transfusion. 43(11). 1634–1638. 29 indexed citations
12.
Leiby, David A., R. Herron, Elizabeth J. Read, Bruce A. Lenes, & Robert J. Stumpf. (2002). Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion. 42(5). 549–555. 144 indexed citations
14.
Spring, F A, et al.. (1990). An Erythrocyte Glycoprotein of Apparent Mr 60,000 Expresses the Sc1 and Sc2 Antigens. Vox Sanguinis. 58(2). 122–125. 9 indexed citations
15.
Herron, R., Graham A. Smith, David Young, & Daniel J. Smith. (1989). Partial Characterisation of the Human Erythrocyte Antigen Pta. Vox Sanguinis. 56(2). 112–116. 4 indexed citations
16.
Ferreiro, Jorge A., Klaus J. Lewin, R. Herron, & Sunita Bhuta. (1989). Malignant Islet Cell Tumor with Rhabdomyosarcomatous Differentiation. The American Journal of Surgical Pathology. 13(5). 422–427. 7 indexed citations
17.
Drake, Thomas A., R. Herron, Janet A. Hindler, O. G. W. Berlin, & David A. Bruckner. (1988). DNA probe reactivity of Mycobacterium avium complex isolates from patients without AIDS. Diagnostic Microbiology and Infectious Disease. 11(3). 125–128. 15 indexed citations
18.
Herron, R., M. Clark, & Daniel J. Smith. (1987). An Autoantibody with Activity Dependent on Red Cell Age in the Serum of a Patient with Autoimmune Haemolytic Anaemia and a Negative Direct Antiglobulin Test. Vox Sanguinis. 52(1-2). 71–74. 6 indexed citations
19.
Herron, R., M. Clark, Deborah Young, & Daniel J. Smith. (1986). Correlation of mononuclear phagocyte assay results andin vivohaemolytic rate in subjects with a positive direct antiglobulin test. Clinical & Laboratory Haematology. 8(3). 199–207. 5 indexed citations
20.
Herron, R., et al.. (1980). An H‐Deficient Blood with Normal H Transferase Levels. Vox Sanguinis. 39(4). 186–194. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026